日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Phase 2 multicenter maintenance study of golidocitinib, A JAK1 selective inhibitor, in patients with peripheral T cell lymphomas after first-line systemic therapy (JACKPOT26)

针对接受一线全身治疗后外周T细胞淋巴瘤患者的 JAK1 选择性抑制剂 golidocitinib 的 II 期多中心维持治疗研究 (JACKPOT26)

Wei, Juying; Cai, Qingqing; Zhang, Liling; Zou, Liqun; Li, Zengjun; Zhou, Keshu; Wu, Huijing; Qiu, Lihua; Su, Liping; Ding, Kaiyang; Zhou, Hui; Yu, Li; Li, Fei; Li, Wenyu; Lin, Li'e; Xiao, Qing; Wang, Erhua; Jing, Hongmei; Zheng, Meifang; Zhang, Hongyu; Gao, Yuhuan; Gao, Da; Chen, Lijia; Jin, Jie

A new candidate tumor suppressor tRF-Ser inhibits gastric cancer progression by regulating the CNBP/HSPA8 axis.

一种新的候选肿瘤抑制因子 tRF-Ser 通过调节 CNBP/HSPA8 轴抑制胃癌进展。

Jiao Jian, Wang Guangchuan, Liu Jin, Xiao Kun, Gao Zi, Dong Daocong, Shan Keshu, Cui Huaiping, Shang Liang, Li Leping, Zhang Chunqing

Transcranial direct current stimulation exerts neuroprotective effects in Parkinson's disease by restoring Mlst8-mediated autophagic homeostasis

经颅直流电刺激通过恢复Mlst8介导的自噬稳态,对帕金森病发挥神经保护作用。

Zekun Tian #,Chao Long #,Juan Wei #,Yan Jiang,Yi Liu,Zhenyu Liu,Manxia Li,Keshu Yang,Chengbiao Ding,Tsung-Hsun Hsieh,Xiaojun Feng

Hypertension Associated with the Risk of Extrahepatic Cancers in the Metabolic Dysfunction-associated Steatotic Liver Disease Population: A Multicenter Cross-sectional Study in China

高血压与代谢功能障碍相关脂肪肝患者肝外肿瘤风险的关联:一项中国多中心横断面研究

Zhao, Xinyue; Xue, Feng; Wang, Shanshan; Ding, Haiyun; Li, Dong; Rao, Huiying; Ji, Fanpu; Jia, Jidong; Ma, Xiong; Hu, Peng; Dou, Xiaoguang; Xu, Keshu; Gao, Shuangqing; Yang, Ming; Wei, Lai

A muscle-centered hierarchical breakdown underlies flight loss during silkworm domestication

以肌肉为中心的等级制度崩溃是家蚕驯化过程中飞行能力丧失的根本原因。

Liu, Rongpeng; Zhao, Chen; Hu, Jie; Ba, Yongbing; Ran, Yiting; Mu, Yuanyuan; Tang, Yiyun; Ma, Yan; Zhang, Zhiming; Guo, Kaiqi; Dong, Keshu; Li, Xiao; Zhu, Yumeng; Tan, Wei; Xu, Hanfu

A comprehensive analysis of pirtobrutinib in Chinese patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL): Results from the phase 3 study BRUIN CLL-321

对中国慢性淋巴细胞白血病/小淋巴细胞淋巴瘤 (CLL/SLL) 患者使用吡托布替尼的综合分析:来自 3 期研究 BRUIN CLL-321 的结果

Yi, Shuhua; Cao, Jiang; Feng, Ru; Zhou, Keshu; Qiu, Lihua; Li, Fei; Yang, Hai Yan; Zhou, Hui; Hui, Wuhan; Cui, Jie; Huang, He; Zhu, Jiankun; Ye, Xiuhui; Sharman, Jeff; Qiu, Lugui

FTO-mediated m(6)A depletion drives prenatal prednisone exposure-induced cortical neurogenesis deficits and long-term anxiety-depression-like behaviors in offspring

FTO介导的m(6)A耗竭导致产前泼尼松暴露引起的子代皮质神经发生缺陷和长期焦虑抑郁样行为。

Neurath, A Robert; Strick, Nathan; Li, Yun-Yao; Qi, Cuiping; Guo, Juanjuan; Zhu, Sen; Liu, Keshu; Liu, Yifan; Luo, Mingcui; Jin, Xiuping; Dai, Gaole; Yang, Pu; Wang, Shouyi; Chen, Xiong; Chen, Huijun; Wang, Hui; Xu, Dan

Emerging therapeutic agents in multiple myeloma: highlights from the 2024 ASH annual meeting

多发性骨髓瘤的新兴治疗药物:2024 年 ASH 年会亮点

Zhang, Qing; Song, Yongping; Zhou, Keshu; Lin, Quande

Efficacy and safety of tazemetostat, an EZH2 inhibitor, in Chinese patients with relapsed/refractory follicular lymphoma: a multicentre, single-arm, phase 2 study

tazemetostat(一种 EZH2 抑制剂)治疗中国复发/难治性滤泡性淋巴瘤患者的疗效和安全性:一项多中心、单臂 II 期研究

Cao, Junning; Chen, Guangliang; Qiu, Lihua; Zhang, Liling; Jiang, Ming; Cheng, Ying; Zhang, Qiaohua; Liu, Lihong; Li, Ping; Shuang, Yuerong; Wang, Huaqing; Xue, Hongwei; Wu, Huijing; Zheng, Meifang; Zhou, Keshu; Li, Zhiming; Jing, Hongmei; Yang, Wei; Zhu, Zunmin; Li, Wenyu; Wangwu, Jiaxuan; Huang, Heyu; Jia, Qiantao; Chen, Dongmei; Fan, Songhua; Shi, M Ming; Su, Weiguo

Capped high-force integrin bond lifetimes and spacing-tuned binding frequency drive rapid fibroblast migration

受限的高力整合素键寿命和间距可调的结合频率驱动成纤维细胞快速迁移

Feng, Jingjing; Feng, Keshu; Xiong, Zhaohui; Yu, Miao; Hu, Yuru; Wang, Wenxu; Xue, Ruihao; Gong, Ze; Liu, Zheng; Chen, Wei